← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

ATPC logoAgape ATP Corporation(ATPC)Earnings, Financials & Key Ratios

ATPC•NASDAQ
$2.72
$136M mkt cap·Price updated May 6, 2026
SectorConsumer DefensiveIndustryPackaged FoodsSub-IndustryNutrition and functional foods
AboutAgape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.Show more
  • Revenue$1M-7.6%
  • EBITDA-$2M-22.0%
  • Net Income-$2M-17.5%
  • EPS (Diluted)-0.63-2174.4%
  • Gross Margin57.39%-12.3%
  • EBITDA Margin-177.41%-32.0%
  • Operating Margin-194.55%-29.7%
  • Net Margin-186.77%-27.2%
  • ROE-78.3%-10.7%
  • ROIC-1623.38%+2.8%
  • Debt/Equity0.19+88.2%
Technical→

ATPC Key Insights

Agape ATP Corporation (ATPC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Share count reduced 16.3% through buybacks

✗Weaknesses

  • ✗Weak Piotroski F-Score: 2/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 7 (bottom 7%)
  • ✗Trading more than 30% below 52-week high
  • ✗Expensive at 89.5x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ATPC Price & Volume

Agape ATP Corporation (ATPC) stock price & volume — 10-year historical chart

Loading chart...

ATPC Growth Metrics

Agape ATP Corporation (ATPC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years9.02%
3 Years9.16%
TTM9.66%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-3.07%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-154.94%

Return on Capital

10 Years-31.95%
5 Years-49.62%
3 Years-68.76%
Last Year-75.77%

ATPC Recent Earnings

Agape ATP Corporation (ATPC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
Q2 2026Latest
Mar 30, 2026
EPS
$10.00
Revenue
—
Q4 2025
Nov 13, 2025
EPS
$0.01
Revenue
$370,593
Q3 2025
Aug 13, 2025
EPS
$0.01
Revenue
$465,499
Q2 2025
May 15, 2025
EPS
$0.07
Revenue
$289,037
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 30, 2026
$10.00
—
Q4 2025Nov 13, 2025
$0.01
$370,593
Q3 2025Aug 13, 2025
$0.01
$465,499
Q2 2025May 15, 2025
$0.07
$289,037
Based on last 12 quarters of dataView full earnings history →

ATPC Peer Comparison

Agape ATP Corporation (ATPC) competitors in Nutrition and functional foods — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NHTC logoNHTCNatural Health Trends Corp.Direct Competitor34.6M3.10-40.42-7.42%-3.03%-4.88%0.13
CLPS logoCLPSCLPS IncorporationDirect Competitor25.89M0.93-3.5615.17%-1.27%-6.06%0.59
USNA logoUSNAUSANA Health Sciences, Inc.Product Competitor369.32M20.0134.508.28%1.16%1.84%0.02
NUS logoNUSNu Skin Enterprises, Inc.Product Competitor353.79M7.342.31-14.26%7.02%13.7%0.35
NATR logoNATRNature's Sunshine Products, Inc.Product Competitor459.31M26.2424.755.67%4.07%11.85%0.12
HLF logoHLFHerbalife Nutrition Ltd.Supply Chain1.7B16.447.470.89%4.67%
VITL logoVITLVital Farms, Inc.Supply Chain537.57M12.008.3325.26%8.73%18.87%0.15
BYFC logoBYFCBroadway Financial CorporationOften Compared86.03M9.25-2.86-3.76%-9.05%0.58

Compare ATPC vs Peers

Agape ATP Corporation (ATPC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NHTC

Most directly comparable listed peer for ATPC.

Scale Benchmark

vs HLF

Larger-name benchmark to compare ATPC against a more recognizable public peer.

Peer Set

Compare Top 5

vs NHTC, CLPS, USNA, NUS

ATPC Income Statement

Agape ATP Corporation (ATPC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemJun'17Jun'18Jun'19Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue0487K1.55M858.72K3.45M1.02M1.86M1.43M1.32M1.48M
Revenue Growth %--217.46%-44.46%302.06%-70.55%82.56%-22.92%-7.57%9.66%
Cost of Goods Sold0441.41K1.44M766.96K775.86K297.33K666.04K494.52K563.6K702.59K
COGS % of Revenue-90.64%92.93%89.31%22.47%29.24%35.88%34.56%42.61%-
Gross Profit
0▲ 0%
45.6K▲ 0%
109.35K▲ 139.8%
91.77K▼ 16.1%
2.68M▲ 2816.9%
719.63K▼ 73.1%
1.19M▲ 65.4%
936.57K▼ 21.3%
759.15K▼ 18.9%
782.31K▲ 0%
Gross Margin %-9.36%7.07%10.69%77.53%70.76%64.13%65.44%57.39%52.68%
Gross Profit Growth %--139.83%-16.08%2816.95%-73.12%65.44%-21.33%-18.94%-
Operating Expenses75.36K276.47K607.36K624.54K2.83M2.58M2.72M3.08M3.33M3.59M
OpEx % of Revenue-56.77%39.28%72.73%82.11%253.52%146.71%215.44%251.94%-
Selling, General & Admin75.36K265.68K607.36K624.54K2.83M2.46M2.72M3.08M3.33M3.44M
SG&A % of Revenue-54.55%39.28%72.73%82.11%241.57%146.71%215.44%251.94%-
Research & Development0000000000
R&D % of Revenue----------
Other Operating Expenses0-14K000121.51K000150.63K
Operating Income
-75.36K▲ 0%
-366.96K▼ 386.9%
-514.51K▼ 40.2%
-532.77K▼ 3.5%
-158.13K▲ 70.3%
-1.86M▼ 1075.3%
-1.53M▲ 17.5%
-2.15M▼ 40.0%
-2.57M▼ 19.9%
-2.81M▲ 0%
Operating Margin %--75.35%-33.28%-62.04%-4.58%-182.76%-82.59%-150%-194.55%-189.02%
Operating Income Growth %74.88%-386.94%-40.21%-3.55%70.32%-1075.3%17.5%-40%-19.88%-
EBITDA0-132.88K-353.37K-677.87K5.34K-1.64M-1.32M-1.92M-2.35M-2.57M
EBITDA Margin %--27.28%-22.86%-78.94%0.15%-161.4%-70.85%-134.4%-177.41%-172.87%
EBITDA Growth %---165.94%-91.83%100.79%-30848.58%19.86%-46.23%-22.01%-1.33%
D&A (Non-Cash Add-back)75.36K234.09K161.14K0163.47K217.21K217.94K223.19K226.65K239.82K
EBIT0-234.09K-131.17K-677.87K-158.13K-1.86M-1.53M-2.15M-2.57M-2.8M
Net Interest Income0000025.57K16.19K29.25K67.93K12.91K
Interest Income0000025.57K16.19K29.25K67.93K12.91K
Interest Expense0000000000
Other Income/Expense0109.15K-5.13K-145.09K674.48K-529.04K-136.87K40.22K92.23K40.99K
Pretax Income
-75.36K▲ 0%
-124.94K▼ 65.8%
-519.64K▼ 315.9%
-677.86K▼ 30.4%
516.35K▲ 176.2%
-2.39M▼ 562.4%
-1.67M▲ 30.1%
-2.11M▼ 26.1%
-2.48M▼ 17.8%
-2.77M▲ 0%
Pretax Margin %--25.65%-33.61%-78.94%14.96%-234.78%-89.96%-147.19%-187.57%-186.26%
Income Tax05.33K00161.58K137.07K-4.05K3.58K4.93K-10.06K
Effective Tax Rate %0%-4.27%0%0%31.29%-5.74%0.24%-0.17%-0.2%0.36%
Net Income
-75.36K▲ 0%
-130.27K▼ 72.9%
-519.64K▼ 298.9%
-677.86K▼ 30.4%
354.77K▲ 152.3%
-2.52M▼ 811.5%
-1.69M▲ 33.2%
-2.1M▼ 24.6%
-2.47M▼ 17.5%
-2.72M▲ 0%
Net Margin %--26.75%-33.61%-78.94%10.28%-248.21%-90.86%-146.88%-186.77%-183%
Net Income Growth %74.88%-72.86%-298.88%-30.45%152.34%-811.52%33.17%-24.61%-17.53%-3.07%
Net Income (Continuing)-75.36K-130.27K-519.64K-677.86K354.77K-2.52M-1.67M-2.11M-2.49M-2.76M
Discontinued Operations0000000000
Minority Interest00000-33620.51K11.78K-3.79K-33.32K
EPS (Diluted)
-0.00▲ 0%
-0.00▼ 50.0%
-0.00▼ 366.7%
-0.00▼ 28.6%
0.00▲ 150.0%
-0.01▼ 844.4%
-0.02▼ 186.6%
-0.03▼ 44.3%
-0.63▼ 2174.4%
-0.05▲ 0%
EPS Growth %--------44.27%-2174.37%-154.94%
EPS (Basic)-0.00-0.00-0.00-0.000.00-0.01-0.02-0.03-0.63-
Diluted Shares Outstanding376.28M376.28M376.28M376.32M376.39M376.22M87.82M75.81M63.49M50.01M
Basic Shares Outstanding376.28M373.28M376.28M376.32M376.39M376.22M87.82M75.85M63.49M50.01M
Dividend Payout Ratio----------

ATPC Balance Sheet

Agape ATP Corporation (ATPC) balance sheet — assets, liabilities & shareholders' equity

Line itemJun'17Jun'18Jun'19Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets2.31M2.71M3.79M3.54M5.68M3.91M2.03M5.19M2.78M24.07M
Cash & Short-Term Investments2.31M1.86M2.86M2.74M3.52M2.6M1.44M4.83M2.04M133.71K
Cash Only2.31M1.86M2.86M238.94K3.52M622.5K1.44M4.83M2.04M133.71K
Short-Term Investments0002.51M01.98M0000
Accounts Receivable0489.84K435.55K523K175.99K1.29K17.9K66.99K58.51K9.74K
Days Sales Outstanding-367.12102.83222.318.610.463.5217.0816.148.8
Inventory0000589.81K676.77K46.28K47.91K46.35K39.89K
Days Inventory Outstanding----277.48830.7925.3635.3630.0220.68
Other Current Assets000269.19K000000
Total Non-Current Assets01.33M860.28K798.62K1.53M812.41K763.22K559.34K463.32K319.04K
Property, Plant & Equipment0000692.45K453.52K223.28K521.49K435.01K290.37K
Fixed Asset Turnover----4.99x2.24x8.31x2.74x3.04x4.11x
Goodwill0000000000
Intangible Assets00005.83K3.66K24.04K17.46K13.08K10.29K
Long-Term Investments01.33M860.28K798.62K578.53K90.5K16.69K20.17K15.24K51.05K
Other Non-Current Assets0000249.53K264.74K499.2K0018.38K
Total Assets
2.31M▲ 0%
5.13M▲ 121.8%
4.65M▼ 9.3%
4.34M▼ 6.8%
7.21M▲ 66.3%
4.72M▼ 34.5%
2.79M▼ 40.9%
5.74M▲ 105.8%
3.24M▼ 43.6%
24.39M▲ 0%
Asset Turnover-0.09x0.33x0.20x0.48x0.22x0.67x0.25x0.41x0.08x
Asset Growth %23127380%121.75%-9.3%-6.8%66.32%-34.48%-40.91%105.77%-43.6%1379.19%
Total Current Liabilities8.1K144.29K71.4K83.99K1.04M1.31M1.23M1.07M1.12M1.49M
Accounts Payable0002.79K013.71K28.83K90.43K102.8K85.14K
Days Payables Outstanding---1.33-16.8415.866.7566.5744.25
Short-Term Debt0003.95K00000143.65K
Deferred Revenue (Current)0000236.13K279.69K363.02K101.58K96.98K383.25K
Other Current Liabilities07.19K077.25K00-384.38K001.16M
Current Ratio285.52x18.77x53.10x42.11x5.47x2.98x1.65x4.84x2.48x2.48x
Quick Ratio285.52x18.77x53.10x42.11x4.91x2.46x1.61x4.79x2.44x2.44x
Cash Conversion Cycle-----814.4113.08-14.3-20.41-14.77
Total Non-Current Liabilities0000247.23K99.06K0292.09K190.78K104.16K
Long-Term Debt000000000104.16K
Capital Lease Obligations0000241.49K83.48K0292.09K190.78K457.4K
Deferred Tax Liabilities00005.74K15.57K0000
Other Non-Current Liabilities0000000000
Total Liabilities8.1K144.29K71.4K83.99K1.29M1.41M1.23M1.36M1.31M1.59M
Total Debt100003.95K395.76K240.58K82.71K437.72K362.78K247.81K
Net Debt-2.31M-1.86M-2.86M-234.99K-3.12M-381.92K-1.36M-4.39M-1.68M114.09K
Debt / Equity0.00x--0.00x0.07x0.07x0.05x0.10x0.19x0.19x
Debt / EBITDA----74.14x-----0.10x
Net Debt / EBITDA-----584.83x-----0.04x
Interest Coverage----------
Total Equity
2.3M▲ 0%
2.56M▲ 11.3%
4.58M▲ 78.6%
4.25M▼ 7.2%
5.92M▲ 39.4%
3.31M▼ 44.1%
1.56M▼ 52.8%
4.38M▲ 180.4%
1.93M▼ 56.0%
22.8M▲ 0%
Equity Growth %9322.28%11.26%78.63%-7.18%39.37%-44.09%-52.83%180.38%-55.96%1843.33%
Book Value per Share0.010.010.010.010.020.010.020.060.030.46
Total Shareholders' Equity2.3M2.56M4.58M4.25M5.92M3.31M1.54M4.37M1.93M22.83M
Common Stock37.13K37.18K37.63K37.63K37.65K29.05K7.54K7.71K3995K
Retained Earnings-100.36K-279.04K-750.28K-1.09M-734.44K-3.26M-4.95M-7.05M-9.52M-11.42M
Treasury Stock0000000-1400
Accumulated OCI03.74K-799.79K181.02K93.4K9.27K30.21K27.85K12.07K
Minority Interest00000-33620.51K11.78K-3.79K-33.32K

ATPC Cash Flow Statement

Agape ATP Corporation (ATPC) cash flow — operating, investing & free cash flow history

Line itemJun'17Jun'18Jun'19Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations-100.26K-347.98K-667.06K-113.94K-557.95K-845.84K-811.68K-2M-2.73M-2.73M
Operating CF Margin %--71.45%-43.15%-13.27%-16.16%-83.17%-43.72%-139.88%-206.1%-
Operating CF Growth %--247.07%-91.7%82.92%-389.67%-51.6%4.04%-146.63%-36.19%30.46%
Net Income-75.36K-130.27K-519.64K-677.86K354.77K-2.52M-1.67M-2.11M-2.49M-2.72M
Depreciation & Amortization0000163.47K217.21K217.94K223.19K226.65K239.82K
Stock-Based Compensation0000000000
Deferred Taxes0000178.33K10.13K-14.75K-2202202
Other Non-Cash Items030.16K474.55K525.23K-510.2K644.05K78.83K24.71K110.69K90.7K
Working Capital Changes-24.9K-247.86K-621.97K156.59K-744.32K807.46K572.38K-139.57K-577.74K-422.8K
Change in Receivables00-511.61K-85.6K-167.57K167.57K21K-45.67K-21.51K4.17K
Change in Inventory000078.67K192.71K343.48K-3.22K-4.22K3.99K
Change in Payables0035.15K-32.31K-2.8K041.42K38.46K39.55K10.04K
Cash from Investing0-1.36M-2.5K-1.5K1.28M-3.96K-32.12K-17.25K-50.05K-23M
Capital Expenditures0000-4.73K-3.96K-9.43K-52.32K-50.16K-2.11K
CapEx % of Revenue----0.14%0.39%0.51%3.66%3.79%-
Acquisitions0-862.49K001.21M00000
Investments----------
Other Investing0-1.36M0-1.5K-1780-22.69K35.07K1121
Cash from Financing2.41M2.93M-5.32K-4.57K-22.09K-19.06K-234.47K5.4M-11.86K23.29M
Debt Issued (Net)2.37M2.93M00000-9.59K-11.86K-21.88K
Equity Issued (Net)1000K1000K000001000K01000K
Dividends Paid0000000000
Share Repurchases0000000-93.89K00
Other Financing-2.36M-2.92M-5.32K-4.57K-22.09K-19.06K-234.47K00313.72K
Net Change in Cash
2.31M▲ 0%
1.22M▼ 47.3%
-673.67K▼ 155.3%
-3.29M▼ 388.7%
773.14K▲ 123.5%
-919.75K▼ 219.0%
-1.16M▼ 26.1%
3.39M▲ 392.7%
-2.79M▼ 182.3%
-2.59M▲ 0%
Free Cash Flow
-100.26K▲ 0%
-347.98K▼ 247.1%
-667.06K▼ 91.7%
-113.94K▲ 82.9%
-562.86K▼ 394.0%
-849.8K▼ 51.0%
-843.8K▲ 0.7%
-2.05M▼ 143.4%
-2.78M▼ 35.2%
-2.85M▲ 0%
FCF Margin %--71.45%-43.15%-13.27%-16.3%-83.56%-45.45%-143.54%-209.89%-192.1%
FCF Growth %--247.07%-91.7%82.92%-393.98%-50.98%0.71%-143.44%-35.16%6.99%
FCF per Share-0.00-0.00-0.00-0.00-0.00-0.00-0.01-0.03-0.04-0.04
FCF Conversion (FCF/Net Income)1.33x2.67x1.28x0.17x-1.57x0.34x0.48x0.95x1.10x1.05x
Interest Paid0000000000
Taxes Paid0000288.93K326.84K78.51K34.84K24K17.51K

ATPC Key Ratios

Agape ATP Corporation (ATPC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201620172018201920202021202220232024TTM
Return on Equity (ROE)-6.61%-5.35%-14.55%-15.35%6.97%-54.65%-69.2%-70.73%-78.3%-11.92%
Return on Invested Capital (ROIC)--78.85%-31.78%-13.92%-3.48%-48.62%-73.3%-1669.61%-1623.38%-1623.38%
Gross Margin-9.36%7.07%10.69%77.53%70.76%64.13%65.44%57.39%52.68%
Net Margin--26.75%-33.61%-78.94%10.28%-248.21%-90.86%-146.88%-186.77%-183%
Debt / Equity0.00x--0.00x0.07x0.07x0.05x0.10x0.19x0.19x
FCF Conversion1.33x2.67x1.28x0.17x-1.57x0.34x0.48x0.95x1.10x1.05x
Revenue Growth--217.46%-44.46%302.06%-70.55%82.56%-22.92%-7.57%9.66%

ATPC SEC Filings & Documents

Agape ATP Corporation (ATPC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 12, 2026·SEC

Material company update

Mar 10, 2026·SEC

Material company update

Feb 6, 2026·SEC

10-K Annual Reports

3
FY 2026

Apr 13, 2026·SEC

FY 2025

Mar 31, 2025·SEC

FY 2024

Apr 1, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 13, 2025·SEC

FY 2025

Aug 13, 2025·SEC

FY 2025

May 15, 2025·SEC

ATPC Frequently Asked Questions

Agape ATP Corporation (ATPC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Agape ATP Corporation (ATPC) reported $1.5M in revenue for fiscal year 2024.

Agape ATP Corporation (ATPC) saw revenue decline by 7.6% over the past year.

Agape ATP Corporation (ATPC) reported a net loss of $2.7M for fiscal year 2024.

Dividend & Returns

Agape ATP Corporation (ATPC) has a return on equity (ROE) of -78.3%. Negative ROE indicates the company is unprofitable.

Agape ATP Corporation (ATPC) had negative free cash flow of $2.9M in fiscal year 2024, likely due to heavy capital investments.

Explore More ATPC

Agape ATP Corporation (ATPC) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.